Drugs / EUR-1100
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01386112 | Sep 2011 → Oct 2012 | eosinophilic esophagitis | Forest Laboratories | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EUR-1100 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01386112 ↗ |
| Route | Oral | “orally administered EUR-1100” NCT01386112 ↗ |